Press release
Metastatic Melanoma Therapeutics Global Market Worth $12.87 Billion By 2028 Rapid Growth Predicted CAGR of 11.8% | Pfizer Inc., AbbVie Inc., Novartis AG, Exelixis Inc., BeiGene Ltd.
Metastatic Melanoma Therapeutics Market
As per the report, the metastatic melanoma therapeutics market size has grown rapidly in recent years. It will grow from $7.27 billion in 2023 to $8.23 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The metastatic melanoma therapeutics market size is expected to see rapid growth in the next few years. It will grow to $12.87 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12065&type=smp
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Market Growth
The rising incidence of melanoma cases is expected to propel the growth of the metastatic melanoma therapeutics market going forward. Melanoma is a form of skin cancer that develops in the cells (melanocytes) that regulate the pigment in the skin. Melanomas can appear anywhere on the skin. Metastatic melanoma therapeutics include a variety of treatments used to block the mutant chemicals and halt the growth of melanoma cells without causing harm to healthy tissue. For instance, in January 2023, according to the American Cancer Society, a US-based voluntary health organization dedicated to eliminating cancer, there will be 58,120 new cases of melanomas diagnosed in males and 39,490 in women in the US in 2023, totaling roughly 97,610, and melanoma deaths are predicted to total around 7,990. Furthermore, in March 2022, according to the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, between 2020 and 2040, there will be a more than 50% increase in cutaneous melanoma cases. In 2020, 325,000 new melanoma cases were predicted to be discovered worldwide, with 57,000 people dying due to the disease. Therefore, the rising incidence of melanoma is driving the growth of the metastatic melanoma therapeutics market.
Product Innovation Trend In Metastatic Melanoma Therapeutics Market
Product innovations are a key trend gaining popularity in the metastatic melanoma therapeutics market. Companies operating in the metastatic melanoma therapeutics market are adopting recent technologies to sustain their position in the market. For instance, in January 2022, Immunocore, a UK-based biotechnology company, announced FDA (Foods and Drugs Association) approval of KIMMTRAK (tebentafusp-tebn) for treating unresectable or metastatic uveal melanoma. KIMMTRAK is the first and only FDA-approved T cell receptor (TCR) therapy. This is the first compound created using the ImmTAC technology platform by Immunocore, intended to reroute and activate T lymphocytes to identify and eliminate tumor cells. It showed a statistically and clinically significant overall survival (OS) advantage, with a hazard ratio of 0.51 and a median overall survival (OS) of almost 22 months.
The metastatic melanoma therapeutics market covered in this report is segmented -
1) By Therapy: Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery
2) By Stages: Stage 0, Stage I, Stage II, Stage III, Stage IV
3) By End User: Hospitals, Specialty Clinics, Home Healthcare, Other End-users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12065&type=discount
Major companies operating in the metastatic melanoma therapeutics market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Ltd., Eisai Co. Ltd., Incyte Corporation, Exelixis Inc., BeiGene Ltd, Immunocore Holdings plc, Genentech Inc., Iovance Biotherapeutics Inc., Nektar Therapeutics, Adaptimmune Therapeutics plc, AIVITA Biomedical Inc., Idera Pharmaceuticals Inc., Evaxion Biotech A/S, AB Science, AgonOX Inc., InxMed Co. Ltd., NewLink Genetics Corporation, Vical Inc.
Contents of the report:
1. Executive Summary
2. Metastatic Melanoma Therapeutics Market Report Structure
3. Metastatic Melanoma Therapeutics Market Trends And Strategies
4. Metastatic Melanoma Therapeutics Market - Macro Economic Scenario
5. Metastatic Melanoma Therapeutics Market Size And Growth
…..
27. Metastatic Melanoma Therapeutics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/metastatic-melanoma-therapeutics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metastatic Melanoma Therapeutics Global Market Worth $12.87 Billion By 2028 Rapid Growth Predicted CAGR of 11.8% | Pfizer Inc., AbbVie Inc., Novartis AG, Exelixis Inc., BeiGene Ltd. here
News-ID: 3592013 • Views: …
More Releases from The Business research company
Machining Centers Market Anticipated To Witness Robust Growth, Surpassing $38.4 …
The Machining Centers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Machining Centers Market Size and Its Estimated Growth Rate?
There has been substantial growth in the size of the machining centres market in the past few years. The market is predicted…
Evolving Market Trends In The Aircraft Cabin Lighting Industry: Led Flex Light F …
The Aircraft Cabin Lighting Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Aircraft Cabin Lighting Market Size During the Forecast Period?
The market size of aircraft cabin lighting has significantly expanded in the past few years. It is projected to escalate from…
Growing Adoption Of Ai Drives The AI In Genomics Market : Key Factor Driving The …
The AI In Genomics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected AI In Genomics Market Size During the Forecast Period?
The market size for AI in genomics has seen a significant increase lately. It's projected to rise from $1.06 billion in…
Aerospace & Defense PCB Industry Report 2025-2034: Market Dynamics, Trends, And …
The Aerospace & Defense PCB Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Aerospace & Defense PCB Market Size During the Forecast Period?
The market size for aerospace and defense PCB has seen a consistent increase in recent times. It is projected…
More Releases for Melanoma
Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
Europe and Israel Mobile Applications for Melanoma Detection Market: Rising prev …
According to the TMR report, the Europe mobile applications for melanoma detection market could collect a larger revenue of around US$1.5 mn by the end of 2022. Even though Greece is dealing with economic volatility, it has been prognosticated to exhibit a perpetually elevating growth until the same year.
Rise in Mortality Rate and Melanoma Incidence Puts Heavy Influence on Early Diagnosis
Europe and Israel mobile applications for melanoma detection market has…
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in…
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Malignant Melanoma
2. Malignant Melanoma Drug Mechanism of Action
3. Global Malignant Melanoma Market Analysis
3.1 Current Market Scenario
3.2 Global Malignant Melanoma Pipeline Overview
4. Global Malignant Melanoma Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Commercialization Challenges
5. Global Malignant Melanoma Drug Market Future Prospects
6. Global Malignant Melanoma Clinical Pipeline By…
